Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Technology Regulatory News (FTV)

Share Price Information for Foresight Technology (FTV)

Share Price is delayed by 15 minutes
Get Live Data
66.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 3.00 (4.762%)
Market Cap: £231.20m
FTV Live PriceLast checked at - London Stock Exchange

Intraday Foresight Technology Share Chart

Portfolio Update

3 Apr 2023 08:00

Portfolio Update

Foresight VCT PLCLEI: 213800GNTY699WHACF46

Sale of portfolio company Innovation Consulting Group Limited (“GovGrant”) delivering a 4.4x cash-on-cash return and an IRR of 24% and exit of portfolio company Datapath Group Limited (“Datapath”) delivering an 11.7x cash-on-cash return and an IRR of 38% for Foresight VCT

The Board of Foresight VCT Plc (“FVCT” or the “Company”) is pleased to announce the sale of two portfolio companies since close of trading on 31 March 2023.

The sale of GovGrant to Source Advisors, a US corporate buyer backed by BV Investment Partners, took place on 31 March 2023. GovGrant is one of the UK’s leading providers of R&D tax relief, patent box relief and other innovation services. The transaction generated proceeds of £6.8 million to FVCT at completion. When added to £0.5 million of cash returned to date, this implies a total cash-on-cash return of 4.4 times the capital of £1.65 million invested in October 2015, equivalent to an IRR of 24%.

Since FVCT made its original investment in 2015, Foresight Group has supported GovGrant through a period of material growth during which it has supported the R&D activities of a growing number of customers. GovGrant’s high levels of service and innovative products, such as the growing patent box offering, have contributed to driving innovation in the UK economy. Foresight Group has taken a proactive approach to supporting the exceptional senior management team, all of whom were introduced to the business during the investment period.

The Board of the Company is also pleased to announce the exit on 31 March 2023 of portfolio company Datapath Group Limited (“Datapath”), a global leader in the provision of visual solutions. The transaction generated proceeds of £5.1 million at completion with an additional £1.2 million payable over the next 24 months. When added to £5.4 million of cash returned to date, this implies a total cash-on-cash return of 11.7 times the original investment, equivalent to an IRR of 38% since the initial investment in 2007.

Since the original investment, Foresight Group has supported Datapath through a period of material growth with revenues growing from approximately £7m to £25m. Datapath has developed a market leading hardware and software product suite for the delivery of multi screen displays and video walls which are sold globally to a diverse customer base across a range of sectors.

Including payment of a 4.0p dividend per share paid in October 2022, the Company’s NAV per Ordinary Share was 85.7p as at 30 September 2022, to which these exits will add 1.5p, giving a pro forma NAV per Ordinary Share of 87.2p.

The sales represent FVCT’s fourth and fifth exits in the last twelve months, following the exits of TFC Europe, Codeplay Software and Mowgli Street Food.

Margaret Littlejohns, Chair of Foresight VCT said: “We are delighted to announce two more positive exits for the Company, following the sale of Mowgli in January. Both GovGrant and Datapath have demonstrated excellent growth and value creation since investment. Each one is a success story for the Company and our shareholders.”

For more information contact:

Gary Fraser, Foresight Group: 0203 667 8181

Date   Source Headline
8th Apr 20257:00 amGNWDividend Declaration
31st Mar 20254:30 pmGNWTotal voting rights
14th Mar 20258:48 amGNWIssue of Equity
12th Mar 20254:26 pmGNWNet Asset Value(s)
28th Feb 20255:59 pmGNWTotal voting rights
17th Feb 202512:28 pmGNWIssue of Equity
10th Feb 20253:58 pmGNWIssue of Equity - Correction
10th Feb 20257:00 amGNWIssue of Equity
4th Feb 20253:15 pmGNWPortfolio Update: Sale of portfolio company Hospital Services Group delivers up to 8.5x return for Foresight VCT PLC
31st Jan 20254:30 pmGNWTotal voting rights
27th Jan 20254:07 pmGNWIssue of Equity
16th Jan 20253:26 pmGNWIssue of Equity
31st Dec 202412:25 pmGNWTotal voting rights
23rd Dec 20247:00 amGNWTransaction in Own Shares
20th Dec 202411:51 amGNWOffer for Subscription - Update
17th Dec 202412:46 pmGNWOFFER UPDATE – USE OF OVER-ALLOTMENT FACILITY
10th Dec 202411:26 amGNWOffer and Prospectus
29th Nov 20247:00 amGNWNet Asset Value(s)
31st Oct 20244:30 pmGNWTotal voting rights
21st Oct 20247:00 amGNWTransaction in Own Shares
25th Sep 20243:39 pmGNWHalf-year report
23rd Jul 202410:11 amGNWIntention to Fundraise
28th Jun 20246:15 pmGNWTotal voting rights
28th Jun 20244:29 pmGNWTransaction in Own Shares
28th Jun 20242:57 pmGNWNotification of Interests of Directors
28th Jun 20242:55 pmGNWIssue of Equity - DRIS
6th Jun 20248:14 amGNWSpecial Dividend Declaration
4th Jun 20244:38 pmGNWAGM Statement
4th Jun 20242:07 pmGNWNet Asset Value(s)
30th May 20244:20 pmGNWNet Asset Value(s)
30th Apr 20244:30 pmGNWTotal voting rights
29th Apr 20244:55 pmGNWTransaction in Own Shares
15th Apr 20246:20 pmGNWFinal Results
9th Apr 20244:02 pmGNWIssue of Equity
8th Apr 20247:33 pmGNWNet Asset Value(s)
28th Mar 20244:30 pmGNWTotal voting rights
21st Mar 20243:09 pmGNWIssue of Equity
11th Mar 20242:30 pmGNWPortfolio Update: Sale of portfolio company Specac International delivers 10.3x return for Foresight VCT PLC
29th Feb 20244:30 pmGNWTotal voting rights
22nd Feb 20244:13 pmGNWIssue of Equity
8th Feb 20243:35 pmGNWIssue of Equity
8th Feb 202412:28 pmGNWNet Asset Value(s)
31st Jan 20244:30 pmGNWTotal voting rights
26th Jan 20243:00 pmGNWOffer for Subscription - Update
11th Jan 20242:32 pmGNWIssue of Equity
29th Dec 20239:52 amGNWTotal voting rights
28th Dec 20235:47 pmGNWTransaction in Own Shares
22nd Dec 202312:25 pmGNWIssue of Equity
20th Dec 20237:00 amGNWOffer Update - Use of Over-Allotment Facility
14th Dec 20234:21 pmGNWDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.